Prof. Dr. Klaus Überla

Lehrstuhl für Klinische und Molekulare Virologie

Influence of AAV vector tropism on long-term expression and Fc-γ receptor binding of an antibody targeting SARS-CoV-2 (2024) Wagner J, Müller-Schmucker S, Wang W, Arnold P, Uhlig N, Issmail L, Eberlein V, et al. Journal article Genetic barrier to resistance: a critical parameter for efficacy of neutralizing monoclonal antibodies against SARS-CoV-2 in a nonhuman primate model (2024) Stahl-Hennig C, Peter AS, Cordsmeier A, Stolte-Leeb N, Vestweber R, Socher E, Merida SA, et al. Journal article Hybrid immunity by two COVID-19 mRNA vaccinations and one breakthrough infection provides a robust and balanced cellular immune response as basic immunity against severe acute respiratory syndrome coronavirus 2 (2024) Almanzar G, Koosha K, Vogt T, Stein A, Ziegler L, Asam C, Weps M, et al. Journal article Clinical and immunological benefits of full primary COVID-19 vaccination in individuals with SARS-CoV-2 breakthrough infections: A prospective cohort study in non-hospitalized adults (2024) Prelog M, Jeske SD, Asam C, Fuchs A, Wieser A, Gall C, Wytopil M, et al. Journal article Oriented display of HIV-1 Env trimers by a novel coupling strategy enhances B cell activation and phagocytosis (2024) Di Vincenzo R, Beutel J, Arnold P, Wang Y, Damm D, Tannig P, Lux A, et al. Journal article Modulation of immune responses to liposomal vaccines by intrastructural help (2023) Damm D, Suleiman E, Wagner J, Klessing S, Pfister F, Elsayed H, Walkenfort B, et al. Journal article Patient-reported reactogenicity and safety of COVID-19 vaccinations vs. comparator vaccinations: a comparative observational cohort study (2023) Werner F, Zeschick N, Kühlein T, Steininger P, Überla K, Kaiser I, Sebastião M, et al. Journal article SARS-CoV-2 Spike Protein Is Capable of Inducing Cell–Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies (2023) Reuter N, CHEN X, Kropff B, Peter AS, Britt WJ, Mach M, Überla K, Thomas M Journal article Reactogenicity and safety of COVID-19 primary immunisation and booster vaccination regimens: a comparative observational cohort study (2023) Warkentin L, Werner F, Zeschick N, Kühlein T, Steininger P, Überla K, Kaiser I, et al. Journal article Propagation of SARS-CoV-2 in a Closed Cell Culture Device: Potential GMP Compatible Production Platform for Live-Attenuated Vaccine Candidates under BSL-3 Conditions? (2023) Klessing S, Peter AS, Fraedrich K, Wagner J, Kummer M, Deutschmann J, Steininger P, et al. Journal article